Healthcare Triangle Statistics
Total Valuation
HCTI has a market cap or net worth of $10.86 million. The enterprise value is $21.84 million.
| Market Cap | 10.86M |
| Enterprise Value | 21.84M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HCTI has 14.97 million shares outstanding. The number of shares has increased by 7,691.61% in one year.
| Current Share Class | 14.97M |
| Shares Outstanding | 14.97M |
| Shares Change (YoY) | +7,691.61% |
| Shares Change (QoQ) | +201.45% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.31% |
| Float | 14.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| Forward PS | 0.55 |
| PB Ratio | 0.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60, with a Debt / Equity ratio of 0.26.
| Current Ratio | 0.60 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.29 |
Financial Efficiency
Return on equity (ROE) is -57.41% and return on invested capital (ROIC) is -24.68%.
| Return on Equity (ROE) | -57.41% |
| Return on Assets (ROA) | -20.87% |
| Return on Invested Capital (ROIC) | -24.68% |
| Return on Capital Employed (ROCE) | -25.55% |
| Weighted Average Cost of Capital (WACC) | 5.68% |
| Revenue Per Employee | $641,850 |
| Profits Per Employee | -$425,575 |
| Employee Count | 40 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HCTI has paid $24,000 in taxes.
| Income Tax | 24,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.59% in the last 52 weeks. The beta is 1.09, so HCTI's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -99.59% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 9.39 |
| Relative Strength Index (RSI) | 42.30 |
| Average Volume (20 Days) | 4,362,925 |
Short Selling Information
The latest short interest is 481,149, so 3.21% of the outstanding shares have been sold short.
| Short Interest | 481,149 |
| Short Previous Month | 347,970 |
| Short % of Shares Out | 3.21% |
| Short % of Float | 3.21% |
| Short Ratio (days to cover) | 1.56 |
Income Statement
In the last 12 months, HCTI had revenue of $25.67 million and -$17.02 million in losses. Loss per share was -$21.48.
| Revenue | 25.67M |
| Gross Profit | 5.53M |
| Operating Income | -14.73M |
| Pretax Income | -17.00M |
| Net Income | -17.02M |
| EBITDA | -13.09M |
| EBIT | -14.73M |
| Loss Per Share | -$21.48 |
Balance Sheet
The company has $2.02 million in cash and $13.00 million in debt, with a net cash position of -$10.98 million or -$0.73 per share.
| Cash & Cash Equivalents | 2.02M |
| Total Debt | 13.00M |
| Net Cash | -10.98M |
| Net Cash Per Share | -$0.73 |
| Equity (Book Value) | 49.10M |
| Book Value Per Share | 11.71 |
| Working Capital | -6.34M |
Cash Flow
In the last 12 months, operating cash flow was -$16.03 million and capital expenditures $547,000, giving a free cash flow of -$15.48 million.
| Operating Cash Flow | -16.03M |
| Capital Expenditures | 547,000 |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | 13.03M |
| Free Cash Flow | -15.48M |
| FCF Per Share | -$1.03 |
Margins
Gross margin is 21.52%, with operating and profit margins of -57.37% and -66.30%.
| Gross Margin | 21.52% |
| Operating Margin | -57.37% |
| Pretax Margin | -66.21% |
| Profit Margin | -66.30% |
| EBITDA Margin | -51.00% |
| EBIT Margin | -57.37% |
| FCF Margin | n/a |
Dividends & Yields
HCTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7,691.61% |
| Shareholder Yield | -7,691.61% |
| Earnings Yield | -156.80% |
| FCF Yield | -142.60% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 36.29% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 10, 2026. It was a reverse split with a ratio of 1:60.
| Last Split Date | Feb 10, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
HCTI has an Altman Z-Score of -1.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.21 |
| Piotroski F-Score | 2 |